About the journal
Cell Research is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,990 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Nature
- ISSN
- 1001-0602 · 1748-7838
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 4,990 EUR
- Declared peer-review model
- peer_review
- Official website
- http://www.cell-research.com/
Index listings
- MEDLINE · 1997-01-01
- PUBMED · 2011-12-06
- Indexing
- MEDLINE · PUBMED
- APC
- 4,990 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 192 days received→accepted — computed from PubMed (n=50)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
4060
Last recorded publication year
2026
h-index
272
i10-index
2688
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 90%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9425763
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Pluripotent Stem Cells Research
- Pluripotent Stem Cells Research
- RNA modifications and cancer
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
Show all subjects (50)
- RNA Research and Splicing
- RNA Research and Splicing
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- RNA and protein synthesis mechanisms
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- interferon and immune responses
- interferon and immune responses
- Cancer-related gene regulation
- Cancer-related gene regulation
- Plant Molecular Biology Research
- Plant Molecular Biology Research
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Mitochondrial Function and Pathology
- Mitochondrial Function and Pathology
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Cancer-related Molecular Pathways
- Immunotherapy and Immune Responses
- Cancer-related Molecular Pathways
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Cancer-related molecular mechanisms research
- Receptor Mechanisms and Signaling
- Cancer-related molecular mechanisms research
- Receptor Mechanisms and Signaling
- MicroRNA in disease regulation
- MicroRNA in disease regulation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ